BARBRA DRODDY: Open Payments
NPI 1740533280 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 73 payments from 16 companies in 2025. Trend: 2023 $564 · 2024 $1,385 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $389 |
| UCB, Inc. | 11 | $246 |
| GENZYME CORPORATION | 10 | $237 |
| ABBVIE INC. | 18 | $207 |
| Organon LLC | 2 | $137 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| Janssen Biotech, Inc. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Lilly USA, LLC | 3 | $67 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
Products named: NEMLUVIO, DUPIXENT, Bimzelx, SKYRIZI, Sotyktu, TREMFYA, EBGLYSS, COSENTYX.
Industry payments across MS — which companies pay providers there.
